Cardioprotective and antiarrhythmic effects ofβ-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Heart and Vessels

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02058353PMID 2573596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Nipradilol, a New β-Blocker, on Leukotriene D4-induced Contraction in Guinea Pig Tracheal Smooth Muscle1-3

  1988cited by this paper
• The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model

  1988cited by this paper
• Prostaglandin I2 analogue and propranolol prevent ischaemia induced mitochondrial dysfunction through the stabilisation of lysosomal membranes.

  1988cited by this paper
• The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model.

  1988cited by this paper
• Effect of nipradilol, a new beta-blocker, on leukotriene D4-induced contraction in guinea pig tracheal smooth muscle.

  1988cited by this paper
• A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.

  1986cited by this paper
• Basic Pharmacokinetics of Bisoprolol, a New Highly Beta1‐selective Adrenoceptor Antagonist

  1986cited by this paper
• Prevention of ventricular fibrillation by metoprolol in a pig model of acute myocardial ischaemia: absence of a major arrhythmogenic role for cyclic AMP.

  1986cited by this paper
• Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.

  1986cited by this paper
• Lysosomal responses of fetal mouse hearts recovering from anoxia and substrate depletion.

  1986cited by this paper
• The effects of β-blocking agents on mitochondrial function in ischemic myocardium

  1985cited by this paper
• The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat.

  1985cited by this paper
• High &bgr;1‐Selectivity and Favourable Pharmacokinetics as the Outstanding Properties of Bisoprolol

  1985cited by this paper
• Dose‐Effect Relationship and Long‐Term Effects of Bisoprolol in Mild to Moderate Hypertension

  1985cited by this paper
• Comparison of Bisoprolol with Other &bgr;‐Adrenoceptor Blocking Drugs

  1985cited by this paper
• Management of Chronic Stable Angina with Once‐Daily Bisoprolol or Atenolol and Long‐Term Efficacy of Bisoprolol

  1985cited by this paper
• Beta-adrenergic blockade for survivors of acute myocardial infarction.

  1984cited by this paper
• The effects of beta-blocking agents on mitochondrial function in ischemic myocardium.

  1984cited by this paper
• β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

  1984cited by this paper
• Reperfusion of ischemic myocardium: ultrastructural and histochemical aspects.

  1983cited by this paper
• Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate.

  1983cited by this paper
• Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.

  1983cited by this paper
• The use of beta-blockers after myocardial infarction.

  1983cited by this paper
• Anterior transmural myocardial infarction: effects of surgical coronary reperfusion on global and regional left ventricular function.

  1983cited by this paper
• The Use of β-Blockers After Myocardial Infarction

  1983cited by this paper
• Characterization of [3H](±)Carazolol Binding to β‐Adrenergic Receptors: Application to Study of β‐Adrenergic Receptor Subtypes in Canine Ventricular Myocardium and Lung

  1981cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.

  1981cited by this paper
• Recovery time course of ventricular vulnerability after coronary reperfusion in relation to mitochondrial function in ischemic myocardium.

  1980cited by this paper
• The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

  1979cited by this paper
• The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

  1979cited by this paper
• STABILIZATION OF LYSOSOMES IN ANOXIC MYOCARDIUM BY PROPRANOLOL

  1979cited by this paper
• Lack of Effect of Methylprednisolone on Lysosomal and Microsomal Enzymes after Two Hours of Weil‐DefinedCanine Myocardial Ischemia

  1978cited by this paper
• Effects of Well‐Defined Ischemia on Myocardial Lysosomal and Microsomal Enzymes in a Canine Model

  1978cited by this paper
• A new technique for isolation of particulate lysosomal activity from canine and rat myocardium.

  1978influential reference
• The Rate-Pressure Product as an Index of Myocardial Oxygen Consumption during Exercise in Patients with Angina Pectoris

  1978cited by this paper
• The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.

  1978cited by this paper
• Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

  1977cited by this paper
• Relations between enzymatically estimated myocardial infarct size and early ventricular dysrhythmia.

  1976cited by this paper
• Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.

  1976cited by this paper
• Protection of the ischemic myocardium. Introductory remarks.

  1976cited by this paper
• Propranolol in the Treatment of Acute Myocardial Infarction: Effect on Myocardial Oxygenation and Hemodynamics

  1974cited by this paper
• Prevention of pulmonary embolism.

  1973cited by this paper
• Estimation of Infarct Size in Man and its Relation to Prognosis

  1972cited by this paper
• Approaches to Sudden Death from Coronary Heart Disease

  1971cited by this paper
• Synthesisof p-Nitrophenyl β-D-Glucopyranosiduronic Acid and Its Utilization as a Substrate for the Assay of β-Glucuronidase Activity

  1960cited by this paper
• INTRODUCTORY REMARKS

  1952cited by this paper

• Medicinal Chemistry and Therapeutic Applications of the Gasotransmitters NO, CO, and H2S and their Prodrugs

  2010cites this paper
• BISOPROLOL INHIBITS SODIUM CURRENT IN VENTRICULAR MYOCYTES OF RATS WITH DIASTOLIC HEART FAILURE

  2007cites this paper
• Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats

  2005cites this paper
• Metoprolol, a Β-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease

  2003cites this paper
• Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.

  1997cites this paper
• Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization.

  1992cites this paper